CAMBRIDGE, Mass., March 20 /PRNewswire-FirstCall/ -- Vertex Pharmaceuticals Incorporated will webcast its corporate presentation at the 2006 Bear Stearns Biotech West Coast Confab. The presentation and discussion will be delivered by Ian Smith, Vertex’s Executive Vice President and Chief Financial Officer, on Thursday, March 23, 2006 at 5:30 p.m. PST (8:30 p.m. EST).
The presentation and discussion will be webcast live and may be accessed by visiting Vertex’s website at http://www.vrtx.com. A replay of the webcast will also be available on the Company’s website until April 6, 2006. To access the webcast, go to Vertex’s website and select ‘2006 Bear Biotech West Coast Confab.’ To ensure a timely connection to the webcast, it is recommended that users register at least 15 minutes prior to the scheduled webcast.
About Vertex
Vertex Pharmaceuticals Incorporated is a global biotechnology company committed to the discovery and development of breakthrough small molecule drugs for serious diseases. The Company’s strategy is to commercialize its products both independently and in collaboration with major pharmaceutical companies. Vertex’s product pipeline is principally focused on viral diseases, inflammation, autoimmune diseases and cancer. Vertex co-promotes the HIV protease inhibitor, Lexiva, with GlaxoSmithKline.
Lexiva is a registered trademark of the GlaxoSmithKline group of companies.
Vertex’s press releases are available at http://www.vrtx.com. Vertex Contact: Lora Pike, Manager, Investor Relations, (617) 444-6755
Vertex Pharmaceuticals Incorporated
CONTACT: Lora Pike, Manager, Investor Relations, of Vertex PharmaceuticalsIncorporated, +1-617-444-6755
Web site: http://www.vrtx.com//
Company News On-Call: http://www.prnewswire.com/comp/938395.html /
